Artificial Intelligence, or AI, is capable of almost everything nowadays. It's one of the biggest arenas on Wall Street getting priority attention. Nvidia became a $1 trillion dollar company on the back of the AI explosion. While investors search for the next winners in AI, one underfollowed NASDAQ company could be positioned for blue-sky growth ahead! Why? Because the company has a unique device that utilizes AI which could help women all over the world. This therapeutic device uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a wide variety of women's health issues.
The company's story is only truly beginning now after its strategic acquisition of innovative AI technology. Key patents have been secured and initial testing has been completed. The company anticipates going to market with this therapeutic device in Q2 2024, which is just around the corner! With a meticulously developed and thoroughly tested product, management believes the product will set new industry benchmarks in a tremendous market. The global women's health market size was valued at USD 41.35 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030.
This message is a PAID ADVERTISEMENT for BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) from InteractiveOffers. StockEarnings, Inc receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $1,000. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) or InteractiveOffers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) on Smallcaps Daily website for additional information about the relationship between InteractiveOffers and BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN).
Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe.
StockEarnings, Inc
33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA
W: 877.6.STOCKS
StockEarnings.com
No comments:
Post a Comment